143 related articles for article (PubMed ID: 25356816)
1. Pigment epithelium-derived factor is associated with necrotic core progression during statin therapy.
Nozue T; Yamagishi S; Hirano T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Hibi K; Terashima M; Michishita I
Coron Artery Dis; 2015 Mar; 26(2):107-13. PubMed ID: 25356816
[TBL] [Abstract][Full Text] [Related]
2. Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Hibi K; Terashima M; Michishita I
Coron Artery Dis; 2014 Jun; 25(4):343-8. PubMed ID: 24448173
[TBL] [Abstract][Full Text] [Related]
3. Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study).
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
Am J Cardiol; 2013 Apr; 111(7):923-9. PubMed ID: 23337838
[TBL] [Abstract][Full Text] [Related]
4. Association between plasma pigment epithelium-derived factor levels and tissue characteristics of coronary plaque using integrated backscatter intravascular ultrasound.
Iwata A; Miura S; Morii J; Yamagishi S; Saku K
Intern Med; 2011; 50(18):1889-94. PubMed ID: 21921365
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Lipids Health Dis; 2014 Apr; 13():59. PubMed ID: 24684829
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.
Nasu K; Tsuchikane E; Katoh O; Tanaka N; Kimura M; Ehara M; Kinoshita Y; Matsubara T; Matsuo H; Asakura K; Asakura Y; Terashima M; Takayama T; Honye J; Hirayama A; Saito S; Suzuki T
JACC Cardiovasc Interv; 2009 Jul; 2(7):689-96. PubMed ID: 19628194
[TBL] [Abstract][Full Text] [Related]
8. Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Hibi K; Terashima M; Michishita I;
Nephrology (Carlton); 2012 Sep; 17(7):628-35. PubMed ID: 22708952
[TBL] [Abstract][Full Text] [Related]
9. Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Am J Cardiol; 2013 Jan; 111(1):6-11. PubMed ID: 23040588
[TBL] [Abstract][Full Text] [Related]
10. Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus: results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Cardiovasc Diabetol; 2014 Jan; 13():13. PubMed ID: 24410834
[TBL] [Abstract][Full Text] [Related]
11. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Statin Therapy on Coronary Plaque Composition Using Virtual Histology Intravascular Ultrasound: A Meta-Analysis.
Zheng G; Li Y; Huang H; Wang J; Hirayama A; Lin J
PLoS One; 2015; 10(7):e0133433. PubMed ID: 26225936
[TBL] [Abstract][Full Text] [Related]
13. Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans.
Tahara N; Yamagishi S; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Mohar D; Ishibashi M; Hayabuchi N; Imaizumi T
Atherosclerosis; 2011 Nov; 219(1):311-5. PubMed ID: 21733518
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease.
Hyogo H; Yamagishi S; Maeda S; Kimura Y; Ishitobi T; Chayama K
Clin Biochem; 2012 Dec; 45(18):1554-7. PubMed ID: 22884488
[TBL] [Abstract][Full Text] [Related]
15. Circulating level of pigment epithelium-derived factor is associated with vascular function and structure: A cross-sectional study.
Kajikawa M; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Kishimoto S; Matsui S; Aibara Y; Hidaka T; Kihara Y; Chayama K; Goto C; Noma K; Nakashima A; Matsui T; Yamagishi SI; Higashi Y
Int J Cardiol; 2016 Dec; 225():91-95. PubMed ID: 27716557
[TBL] [Abstract][Full Text] [Related]
16. Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque.
Kojima S; Kojima S; Maruyoshi H; Nagayoshi Y; Kaikita K; Sumida H; Sugiyama S; Funahashi T; Ogawa H
Int J Cardiol; 2011 Mar; 147(3):371-6. PubMed ID: 19896734
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of pigment epithelium-derived factor, a novel marker of insulin resistance, are independently associated with fasting apolipoprotein B48 levels in humans.
Tahara N; Yamagishi S; Tahara A; Takeuchi M; Imaizumi T
Clin Biochem; 2012 Nov; 45(16-17):1404-8. PubMed ID: 22827961
[TBL] [Abstract][Full Text] [Related]
18. Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study).
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
Am J Cardiol; 2012 May; 109(9):1247-53. PubMed ID: 22325089
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome.
Yamagishi S; Adachi H; Abe A; Yashiro T; Enomoto M; Furuki K; Hino A; Jinnouchi Y; Takenaka K; Matsui T; Nakamura K; Imaizumi T
J Clin Endocrinol Metab; 2006 Jun; 91(6):2447-50. PubMed ID: 16522692
[TBL] [Abstract][Full Text] [Related]
20. Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis.
Terawaki H; Yamagishi S; Funakoshi Y; Matsuyama Y; Terada T; Nakayama K; Ogura M; Hosoya T; Ito S; Era S; Nakayama M
Ther Apher Dial; 2013 Dec; 17(6):625-30. PubMed ID: 24330558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
